UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 6, 2009
REHABCARE GROUP, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 0-19294 | 51-0265872 |
| (State or other jurisdiction | (Commission File Number) | (I.R.S. Employer |
| of incorporation) | | Identification No.) |
| | 7733 Forsyth Boulevard | |
| | Suite 2300 | |
| | St. Louis, Missouri | 63105 |
| | (Address of principal executive offices) | (Zip Code) |
(800) 677-1238
(Company’s telephone number, including area code)
Not applicable
(Former name or former address if changed since last report)
| | Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions. |
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| | | | |
| Item 2.02 | | Results of Operations and Financial Condition | |
| | | | |
| | | The information in Exhibit 99.1 is incorporated herein by reference. | |
| | | | |
| Item 7.01 | | Regulation FD Disclosure | |
| | | | |
| | | During a conference call held by RehabCare Group, Inc. (“the Company”) on August 6, 2009, Dr. John Short, President and Chief Executive Officer of the Company, was asked about the costs related to mergers and acquisitions and the Company’s recent shelf registration statement on Form S-3. Dr. Short responded that the Company is evaluating a transaction to achieve scale in its hospital division but that the completion of such transaction was not certain at this time. | |
| | | | |
| | | The information in Exhibit 99.2 is incorporated herein by reference. | |
| | | | |
| Item 9.01 | | Financial Statements and Exhibits | |
| | | | |
| (d) | | Exhibits | |
| | | | |
| | | The following exhibits are furnished pursuant to Item 2.02 and 7.01 hereof and should not be deemed to be “filed” under the Securities Exchange Act of 1934: | |
| | | | |
| | 99.1 | Press release dated August 5, 2009, announcing our second quarter and year to date revenues and results of operations. | |
| | | | |
| | 99.2 | The script for a conference call held by the registrant on August 6, 2009 | |
| | | | |
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: August 6, 2009
| | By: /s/ | Jay W. Shreiner |
| | Jay W. Shreiner |
| | Executive Vice President and |
| | Chief Financial Officer |
EXHIBIT INDEX
| Exhibit No. | | | Description |
| 99.1 | | Press release dated August 5, 2009, announcing our seccond quarter and year to date revenues and results of operations. |
| | | |
| 99.2 | | The script for a conference call held by the registrant on August 6, 2009 |
| | | |
